ALHC | Ticker Profile - Titan Protect

ALHC

Alignment Healthcare, Inc.

Healthcare · Healthcare Plans · NMS

$15.37

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$3.3B

Total market value of the company

Trailing P/E

159.30

Expensive — high growth expected

Forward P/E

22.05

Based on estimated future earnings — lower means cheaper

Rev Growth

+33.3%

Year-over-year revenue change

Profit Margin

0.5%

How much profit the company keeps from each dollar of revenue

ROE

12.5%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$25.00

+63% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 13 analysts covering this stock

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

https://www.alignmenthealth.com

Country: United States Employees: 1,849 Industry: Healthcare Plans

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

1.020

Excellent risk-adjusted returns

Kelly Fraction

0.0759

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.243

Returns exceed worst-case losses — strong risk profile

Annual Return

51.1%

Historical annualised return based on price data

Max Drawdown

-41.2%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.27

Moves slightly more than the broader market

52W High

$23.87

36% below the year high

52W Low

$11.63

32% above the year low

Avg Volume

4,486,091

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

12.5%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.10

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

159.49

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.58

Healthy liquidity position

Quick Ratio

1.39

Like current ratio but excludes inventory — stricter test

Gross Margin

12.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

1.3%

Profit from core operations before interest and tax

Free Cash Flow

$235M

Positive — the business generates more cash than it spends

Revenue (TTM)

$4.3B

Total revenue over the last 12 months

Net Income

$20M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$30.00

Target Median

$25.00

Target Low

$16.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go